Paperless validation means running the whole validation lifecycle in a controlled electronic system: requirements, risk assessments, protocols, test execution, evidence, approvals and traceability, with no printed protocol and no wet-ink signature anywhere in the record. Paperless validation software, also sold as digital validation software or a validation lifecycle management system (VLMS), is the system that holds that record and makes it acceptable to an inspector under 21 CFR Part 11 and EU GMP Annex 11.
This guide covers what the software has to do, the regulatory basis, the products buyers actually shortlist in 2026 and how to choose between them. We make one of those products, Cybroscape Cybroscape GxP Copilot, so read the vendor section as a positioned view. We have described every product, ours included, only from what its maker publishes, and we have said where each one fits better than ours.
What paperless validation is, and what it is not
Scanning a signed paper protocol into a PDF is not paperless validation. Neither is emailing Word documents for approval and filing them on a shared drive. In both cases the controlled record is still paper or an uncontrolled file, and the system around it adds no assurance.
A paperless validation system holds structured content. Each requirement, risk, test step and result is a record the system understands, with its own author, timestamp, status and audit trail. Execution happens inside the system, evidence is attached to the step it proves, and the traceability matrix is generated from the links between records instead of being maintained by hand in a spreadsheet. That is what removes the reconciliation work that makes paper validation slow, and it is what an inspector can query directly.
The terms overlap. "Paperless validation" describes the end state. "Digital validation" is the term Gartner uses for the market (its Peer Insights category is called Digital Validation Tools for Life Sciences), and "validation lifecycle management" is the older industry name. Most vendors use all three for the same category of product.
The regulatory basis: no rule requires paper
No GxP regulation requires validation to be done on paper. 21 CFR Part 11 exists to set the conditions under which electronic records and electronic signatures are treated as equivalent to paper records and handwritten signatures. EU GMP Annex 11 sets the equivalent expectations for computerised systems in the EU. The FDA's Computer Software Assurance guidance (finalised in September 2025 and reissued in February 2026) goes further in the same direction: it asks for testing effort that follows risk and for records that capture the decision, not for volumes of printed scripts.
What a paperless system must therefore show is the same set of controls paper relied on, made stronger: who did what and when (attributable, contemporaneous records under ALCOA+), signatures that cannot be repudiated, records that cannot be altered without a trace, and retrieval of the complete record for the life of the system. When teams stay on paper, the reason is almost always their own SOPs, written when compliant electronic systems were rare. Updating those SOPs through change control is the real first step of any paperless project.
What paperless validation software has to do
These are the capabilities to test in every demo. Ask the vendor to show each one on your own material, not on their sample project.
- Electronic execution of protocols, with each step recorded against the person who ran it, the time and the actual result. No printing and no scan-and-upload.
- Part 11 electronic signatures that capture the signer, the date and time and the meaning of the signature (authored, reviewed, approved), with re-authentication at signing.
- Evidence attached to the step it proves: screenshots, exports, instrument printouts and data files, all under the same audit trail.
- A traceability matrix generated from the links between requirements, risks, tests and results, which updates as tests pass or fail.
- An audit trail that records every create, change, review and approval, and signed records that cannot be edited afterwards.
- Deviation handling during execution, so a failed step opens a controlled record instead of a note in the margin.
- Coverage of the work you actually do: computer system validation, equipment and instrument qualification, or both. Several products are strong in one and thin in the other.
- Offline or low-connectivity execution if you test on a manufacturing floor or in a cleanroom.
- A supplier qualification package from the vendor, so validating the validation system itself is a short, risk-based exercise.
- Export of the complete executed record in a form an inspector can read without access to the system.
Paperless validation software buyers shortlist in 2026
These are the products that appear most often on life sciences shortlists and in search results for this category. Each description comes from the vendor's own published material. Products change quickly, so confirm current capability in a scripted demo.
Kneat Gx
Kneat is one of the two most established names in paperless validation, widely used in pharmaceutical and biotech manufacturing. Its platform treats validation documents as structured, data-aware content, so execution and traceability operate on records the system understands. Buyers tend to value the execution experience and the directness of traceability. It suits organisations that want a clear, opinionated process. Our Kneat alternatives post covers when to stay with it.
ValGenesis
ValGenesis is long established in large pharmaceutical manufacturing and is known for breadth and configurability across the validation lifecycle, including multi-site approval structures. It has been adding AI through its VAL assistant, relaunched in April 2026 for protocol and trace generation, gap assessment and execution review, initially as a limited pilot. The trade-off buyers report is implementation effort in large organisations and the need to own the configuration. See ValGenesis vs Kneat for the detail.
Veeva Validation Management
Part of Veeva's Vault quality suite. Veeva describes it as covering commissioning, qualification and validation across computerised systems, facilities, utilities, equipment and processes, with digital test execution and automatically generated traceability and summary reports, unified with Veeva QualityDocs and QMS. Veeva lists it as announced in 2021 with 11 to 50 customers. The strongest case for it is consolidation if you already run quality on Vault. See Veeva Vault validation alternatives.
Sware Res_Q
Sware positions Res_Q as an AI-driven, SaaS validation platform with what it calls agentic validation across the lifecycle, built on the Res_Q Data Cloud of curated validation knowledge. It is particularly associated with validating cloud and SaaS applications, where vendor releases arrive on the vendor's schedule. It suits companies whose validation load is mainly a portfolio of business systems.
Valkit.ai
Valkit.ai describes itself as second-generation digital validation for authoring, executing and signing CQV, CSV and CSA work in one place, with Part 11 support, no seat limits and implementation in weeks. It publishes figures of more than 12,000 documents digitised and more than 2,000 users across North America, Europe and Asia, and a framework for human-in-the-loop AI. It suits teams that want a newer product with a fast start.
GoVal
GoVal markets a modular paperless validation suite designed for 21 CFR Part 11 and Annex 11, with an emphasis on reducing validation cost and an AI module. It suits mid-sized manufacturers looking for a cost-focused replacement for paper.
FIVE Validation
FIVE Validation offers cloud, fully paperless validation and qualification with an automatic traceability matrix, an item-based approach, adaptable templates and unlimited users, and says it is used by pharmaceutical companies in 11 countries. Its compliance messaging covers FDA, EMA, ANVISA and WHO, which makes it a common choice in Latin American markets.
Services-led options
Some providers, QbD Group among them, combine paperless validation software with implementation and validation services. That suits teams that lack the people to run the migration themselves. Ask which software sits underneath and who owns it after go-live.
Cybroscape GxP Copilot
Our product, which starts from a different point. Most platforms above digitised the execution of documents that people still write. Cybroscape GxP Copilot drafts the validation package itself from one intake (requirements, risk assessment, test cases and a live traceability matrix) under a CSV or CSA approach. Qualified people review, edit and sign every deliverable with Part 11 electronic signatures, execution evidence sits in a tamper-evident audit trail, and test automation runs only what a person has approved. It fits teams whose bottleneck is authoring capacity, typically mid-sized pharma, biotech and CDMOs. It is not the right choice if you need a long track record across hundreds of sites or a vendor already embedded in your global quality systems.
How to choose between them
Most disappointing selections began with the wrong diagnosis. Before any demo, write down which problem you are solving, because each one points to a different shortlist.
- If execution on paper is the problem (lost protocols, slow signature routing, manual traceability), any mature paperless platform will fix it. Choose on usability, coverage of your asset types and cost at your size.
- If authoring is the problem, meaning your team spends most of its time writing requirements, risk assessments and test scripts, test how much each product drafts today on your own system, and how much editing the draft needs.
- If consolidation is the problem, favour the platform your quality system already runs on, even if another product demos better.
- If your load is mostly SaaS releases, favour tools built around cloud application validation and automated regression testing.
Then run the same scripted demo with every finalist. Give each the same system, the same five requirements and the same failed test step, and score them on the same criteria set before the first demo. Our guide on how to choose a validation platform includes a scoring template.
Moving from paper to paperless in about 90 days
Weeks 1 and 2: update the SOPs
List every validation SOP that mandates paper, print or wet ink, and revise it under change control to permit electronic execution and electronic signatures as equivalents. This is usually the slowest approval in the whole project, so start it first.
Weeks 3 and 4: qualify the platform
Install or subscribe, then validate the validation system using the vendor's supplier qualification package and a risk-based approach. The customer-side effort depends on how much you configure.
Weeks 5 to 8: run one real project
Take your next scheduled validation, such as a periodic review, a new system or a change-driven revalidation, and run it entirely in the new system. Record cycle time, review comments and deviations against your last comparable paper project. Those numbers are what convince QA and management.
Weeks 9 to 12: scale and stop printing
Move all new projects to the platform, train the team, update the validation master plan and decide how legacy paper records will be retained. Set a date after which no new paper protocol may be opened, or the hybrid state tends to last for years.
Why paper lingers, and how to avoid a hybrid that never ends
Teams that buy a paperless system and still print usually have one of three reasons: an SOP that was never changed, a reviewer who does not trust the electronic signature, or a site where connectivity is poor. Each has a direct fix. Change the SOP, walk the reviewer through the audit trail and signature manifest once, and choose a product that executes offline where you need it. Keeping printed copies "just in case" creates two records of the same activity, which is a data integrity question in itself, so retire the paper copy formally instead of letting it run in parallel.
Where to go next
Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.